Transcription factor PRRX1-activated ANXA6 facilitates EGFR-PKCα complex formation and enhances cisplatin sensitivity in bladder cancer DOI

Jinlong Cao,

Siyu Chen, Jirong Wang

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: 359, P. 123228 - 123228

Published: Nov. 9, 2024

Language: Английский

Design and biomedical application of Cr3+-doped gallate near-infrared persistent luminescence nanoprobes DOI
Jie Gao, Yuan Lin,

Yu Min

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: 505, P. 159183 - 159183

Published: Jan. 5, 2025

Language: Английский

Citations

1
Drug delivery for platinum therapeutics DOI
Hui Liu, Jiahui Zou, Xiaotong Li

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 380, P. 503 - 523

Published: Feb. 11, 2025

Language: Английский

Citations

0
Supramolecular charge-reversal pillar[6]arenes-oxaliplatin system for cancer therapy with reduced toxicity and enhanced efficacy DOI
Ping Yang, Kairong Zhao, Shuai Zhao

et al.

Journal of Industrial and Engineering Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0
FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis DOI
Xiaoyu Wang, Chunming Xu, Hui Tian

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: unknown, P. 137479 - 137479

Published: March 1, 2025

Language: Английский

Citations

0
Quantification of Cisplatin Encapsulated in Nanomedicine: An Overview DOI Creative Commons
Ziwen Zhang, Jiayu Chen, Tao Wen

et al.

Biosensors, Journal Year: 2025, Volume and Issue: 15(5), P. 293 - 293

Published: May 6, 2025

Cisplatin, which kills cancer cells mainly through DNA crosslinking, has been widely used as a first-line chemotherapeutic agent although it also causes severe side effects. To improve anticancer outcomes, various types of cisplatin-based nanomedicines have developed, either direct incorporation or coordination cisplatin within nanoparticles (NPs). During the formulation and characterization cisplatin-loaded NPs, quantitative determination is crucial for both clinically newly developed NPs. While NPs facilitate delivery, use different nanomaterials inevitably complicates its increases cost quantification. Currently, there still significant demand an accurate, simple, cost-effective method to determine in would screening quality control nanomedicines. This review aims discuss main strategies quantifying cisplatin, following summary Application examples are provided, key features each quantification strategy compared. In addition, NP-based electrochemical sensors included emerging approach characterizing loaded Rational selection appropriate according principle specific drug-delivery settings highly recommended.

Language: Английский

Citations

0
Hyaluronic acid-coated Zein Nanoparticle-Mediated Resveratrol Therapy for the Reduction of Cisplatin-Associated Nephrotoxicity DOI
Ning Yuan, Ping Chen,

Zhengnan Shen

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2024, Volume and Issue: 736, P. 150873 - 150873

Published: Oct. 23, 2024

Language: Английский

Citations

0
LncRNA-Mediated Regulation of Cisplatin Response in Breast Cancer DOI
Shirin Azizidoost, Mohadeseh Sheykhi-Sabzehpoush,

Mahrokh Abouali Gale Dari

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 264, P. 155716 - 155716

Published: Nov. 7, 2024

Language: Английский

Citations

0
Transcription factor PRRX1-activated ANXA6 facilitates EGFR-PKCα complex formation and enhances cisplatin sensitivity in bladder cancer DOI

Jinlong Cao,

Siyu Chen, Jirong Wang

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: 359, P. 123228 - 123228

Published: Nov. 9, 2024

Language: Английский

Citations

0